Mitä "Tyhjennä" tarkoittaa?
Eläin ei kanna mutaatiota. Se ei kehitä tautia eikä anna sitä eteenpäin.
Kissa Alfamannosidoosi (AlphaMan)
Alpha Mannosidosis (AlphaMan) is a rare genetic disorder affecting cats, caused by a deficiency of the enzyme alpha-mannosidase. This DNA test helps identify carriers and affected cats, enabling responsible breeding decisions to prevent the spread of the disease. Early detection through the Alpha Mannosidosis DNA test is crucial for managing symptoms and improving feline health. By screening your cat, you contribute to reducing the incidence of AlphaMan in future generations. Trusted by veterinarians and breeders, this test provides accurate and reliable results. Ensure your cat’s well-being with the Alpha Mannosidosis DNA test today. Protect your feline companion from hereditary health risks with this essential genetic screening.
Lyhenne: AlphaMan
Analysoitu mutaatio: MAN2B1 c.1749_1752del
Perintö: Autosomaalinen resessiivinen
Lyhenne
AlphaMan
Havaittu taajuus
Kliininen vakavuus
Kliininen luokitus
Metaboliset sairaudet
Analysoitu mutaatio
MAN2B1 c.1749_1752del
p.(Q584Afs)
p.(Q584Afs)
Periytymistapa
Autosomaalinen resessiivinen
Testin yhteenveto:
Alpha Mannosidosis (AlphaMan) is a rare genetic disorder in cats caused by a deficiency of the enzyme alpha-mannosidase. This leads to the accumulation of complex sugars in cells, resulting in progressive neurological and physical symptoms. A DNA test for AlphaMan helps identify carriers and affected cats, enabling responsible breeding decisions. Early detection through testing can improve management and care for affected cats. Genetic screening is essential to reduce the incidence of this debilitating condition in feline populations.
Saatavilla pakkauksesta: Basic
Tämä DNA-testi sisältyy pakettiin alkaen Basic — ja se on myös osa paketteja Basic, Standard, Advanced, Complete.
Katso DNA-testipaketit →Valitse pakkaus, joka sopii parhaiten eläinten jalostukseen tai terveysstrategiaan.
Understanding Alpha Mannosidosis in Cats
Alpha Mannosidosis (AlphaMan) is a rare genetic disorder that affects the metabolism of certain sugars in the body. It is caused by a deficiency in the enzyme alpha-mannosidase, which is responsible for breaking down mannose-containing oligosaccharides. When this enzyme is deficient or absent, these sugars accumulate in the body's cells, leading to a range of health issues.
Symptoms and Clinical Manifestations
Cats with Alpha Mannosidosis may exhibit a variety of clinical symptoms that can vary in severity. Common signs include neurological deficits, such as poor coordination, muscle weakness, and behavioral changes. Additionally, affected cats might experience growth delays, skeletal abnormalities, and impaired immune function. The onset of symptoms can occur at different ages, often leading to a progressive decline in health over time.
Diagnosis of Alpha Mannosidosis
Diagnosing Alpha Mannosidosis typically involves a combination of clinical evaluation and laboratory testing. A veterinarian will assess the cat's medical history and symptoms, followed by conducting biochemical tests to measure enzyme activity. Genetic testing through DNA analysis can confirm the presence of mutations in the gene responsible for encoding the alpha-mannosidase enzyme, providing a definitive diagnosis.
Hoito- ja hoitovaihtoehdot
Currently, there is no cure for Alpha Mannosidosis, and treatment is primarily supportive. Management strategies may include symptomatic care to improve the quality of life for affected cats. This can involve nutritional support, physical therapy, and regular veterinary check-ups to monitor the animal's condition. Research is ongoing to explore potential therapeutic options, including enzyme replacement therapy and gene therapy, which may offer hope for future treatments.
The Importance of Genetic Testing
Genetic testing for Alpha Mannosidosis is crucial for breeders and pet owners to identify carriers of the gene mutation and prevent the propagation of this disorder. By understanding the genetic status of their cats, responsible breeding practices can be implemented to reduce the risk of this condition in future generations. Additionally, early detection through DNA testing can help owners make informed decisions regarding the health management of their pets.
Testissä tunnustettu rotu: Alfamannosidoosi (AlphaMan)
- Persian
🧬 Interpretation of genotypes AlphaMan
Genotyyppi
Status
🟡 N/N
Ei liikenteenharjoittaja - Ei riskiä
🟡 N/AlphaMan
Kuljetin - Ei riskiä
❌ AlphaMan/AlphaMan
Vaikutus – vaarassa
FAQ: tulkinnan ymmärtäminen
Onko "Kantaja" tosissaan?
Ei. Eläin on yleensä terve, mutta voi välittää mutaation sen jälkeläisiä.
Entä jos eläin on "vaikuttunut"?
Se sisältää kaksi mutatoitua kopiota. Kliinisiä oireita odotetaan riippuen tauti. Sitä ei pidä kasvattaa.
Miksi miehen/naisen välillä on eroja?
Jotkut sairaudet ovat sukupuoleen liittyviä, joten niiden ilmeneminen vaihtelee riippuen eläimen sukupuoli.
Ennusta jälkeläisiä
N/N (ei-kuljettaja)
N/AlphaMan (Kuljettaja)
AlphaMan/AlphaMan (Vaikuttaa)
DNA-testin UKK
Mitä tämä DNA-testi havaitsee?
This DNA test detects the mutation associated with Alpha Mannosidosis (AlphaMan) in order to identify clear, carrier, or at-risk animals.
Miksi testata siitoseläintä?
DNA-testaus auttaa kasvattajia suunnittelemaan turvallisempia pariutuksia ja vähentämään mutaation siirtymisen riskiä jälkeläisiin.
Mikä on tämän testin periytymismuoto?
Tässä testissä raportoitu periytymistila on autosomaalinen resessiivinen.
Mitä mutaatiota tässä testissä analysoidaan?
This test analyses the mutation MAN2B1 c.1749_1752del.
Vaikuttaako kantajaeläimeen välttämättä?
Ei välttämättä. Tulkinta riippuu perinnöllisyysmallista ja tuloksena olevasta genotyypistä.
Viitteet
Berg T, Tollersrud O K, Walkley S U, Siegel D, Nilssen O. Purification of feline lysosomal alpha-mannosidase, determination of its cDNA sequence and identification of a mutation causing alpha-mannosidosis in Persian cats. Biochem J. 1997 Dec 15;328 ( Pt 3)(Pt 3):863-70. doi: 10.1042/bj3280863.